FI865227A - Foerfarande foer framstaellning av ett depot-preparat. - Google Patents

Foerfarande foer framstaellning av ett depot-preparat. Download PDF

Info

Publication number
FI865227A
FI865227A FI865227A FI865227A FI865227A FI 865227 A FI865227 A FI 865227A FI 865227 A FI865227 A FI 865227A FI 865227 A FI865227 A FI 865227A FI 865227 A FI865227 A FI 865227A
Authority
FI
Finland
Prior art keywords
preparat
ett
depot
foerfarande foer
foer framstaellning
Prior art date
Application number
FI865227A
Other languages
English (en)
Other versions
FI88580C (fi
FI88580B (fi
FI865227A0 (fi
Inventor
Pyare Lal Seth
Original Assignee
Mepha Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mepha Ag filed Critical Mepha Ag
Publication of FI865227A0 publication Critical patent/FI865227A0/fi
Publication of FI865227A publication Critical patent/FI865227A/fi
Application granted granted Critical
Publication of FI88580B publication Critical patent/FI88580B/fi
Publication of FI88580C publication Critical patent/FI88580C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Control Of El Displays (AREA)
  • Manufacturing Of Tubular Articles Or Embedded Moulded Articles (AREA)
FI865227A 1986-06-25 1986-12-19 Foerfarande foer framstaellning av ett depotpreparat av ibuprofen FI88580C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH255386 1986-06-25
CH2553/86A CH669523A5 (fi) 1986-06-25 1986-06-25

Publications (4)

Publication Number Publication Date
FI865227A0 FI865227A0 (fi) 1986-12-19
FI865227A true FI865227A (fi) 1987-12-26
FI88580B FI88580B (fi) 1993-02-26
FI88580C FI88580C (fi) 1993-06-10

Family

ID=4236387

Family Applications (1)

Application Number Title Priority Date Filing Date
FI865227A FI88580C (fi) 1986-06-25 1986-12-19 Foerfarande foer framstaellning av ett depotpreparat av ibuprofen

Country Status (18)

Country Link
US (1) US4867987A (fi)
EP (1) EP0250648B1 (fi)
JP (1) JPS635020A (fi)
KR (1) KR930008956B1 (fi)
CN (1) CN1023191C (fi)
AT (1) ATE66370T1 (fi)
AU (1) AU590370B2 (fi)
CA (1) CA1276560C (fi)
CH (1) CH669523A5 (fi)
DE (1) DE3681031D1 (fi)
DK (1) DK616186A (fi)
ES (1) ES2029228T3 (fi)
FI (1) FI88580C (fi)
GR (1) GR3002579T3 (fi)
IL (1) IL81045A (fi)
NO (1) NO173081C (fi)
NZ (1) NZ218734A (fi)
ZA (1) ZA869586B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
US4970081A (en) * 1989-01-03 1990-11-13 Sterling Drug Inc. Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
US5213807A (en) * 1990-05-03 1993-05-25 Chemburkar Pramod B Pharmaceutical composition containing ibuprofen and a prostaglandin
JPH04230625A (ja) * 1990-12-27 1992-08-19 Standard Chem & Pharmaceut Corp Ltd 噴霧乾燥したジクロフェナクナトリウムを含み腸溶性の被覆を有するマイクロカプセルからなる微分散した錠剤組成物の製造方法
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
EP1338275B1 (en) * 2000-11-28 2012-02-29 Nartsissov, Yaroslav Pharmaceutical composition, the use thereof and method for producing said composition
ES2677769T3 (es) 2002-09-20 2018-08-06 Alpharma Pharmaceuticals Llc Subunidad secuestrante y composiciones y procedimientos relacionados
EA012315B1 (ru) * 2005-02-04 2009-08-28 Филип Моррис Продактс С.А. Сигарета и фильтр с ароматизирующей добавкой на основе целлюлозы
DE102005037630A1 (de) 2005-08-09 2007-02-15 Glatt Gmbh Verfahren zur Herstellung von Teilchen aus pharmazeutischen Substanzen, Teilchen aus pharmazeutischen Substanzen sowie deren Verwendung
CA2633266C (en) * 2005-12-16 2011-08-02 Hanmi Pharm. Co., Ltd. Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same
ES2385612T3 (es) 2006-06-19 2012-07-27 Alpharma Pharmaceuticals, Llc Composiciones farmacéuticas
US20080233156A1 (en) * 2006-10-11 2008-09-25 Alpharma, Inc. Pharmaceutical compositions
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
WO2009079521A1 (en) * 2007-12-17 2009-06-25 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
JP5953646B2 (ja) * 2009-11-24 2016-07-20 大正製薬株式会社 イブプロフェン含有固形製剤
CN102869349A (zh) * 2010-03-09 2013-01-09 阿尔科米斯制药爱尔兰有限公司 耐酒精的肠溶药物组合物
CA3018328A1 (en) 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1228757B (de) * 1962-06-28 1966-11-17 Haessle Ab Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen
JPS51127041A (en) * 1975-04-23 1976-11-05 Toyama Chem Co Ltd A process for preparing novel 2-( substituted phenyl) alkane acids and their salts.
US4447454A (en) * 1977-04-01 1984-05-08 The Upjohn Company Analgetic compounds, compositions and process of treatment
CA1125698A (en) * 1978-03-09 1982-06-15 Masaru Yoshida Process for preparing a polymer composition
JPS6028809B2 (ja) * 1979-08-21 1985-07-06 日本原子力研究所 イブプロフエン徐放剤組成物の製造方法
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
US4713249A (en) * 1981-11-12 1987-12-15 Schroeder Ulf Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
DE3205504C2 (de) * 1982-02-16 1983-12-01 Dolorgiet Gmbh & Co Kg, 5300 Bonn Äußerlich anwendbares, Ibuprofen enthaltendes Arzneimittel
US4486436A (en) * 1982-07-22 1984-12-04 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
ZA835326B (en) * 1982-07-22 1984-09-26 Richardson Vicks Inc Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4587249A (en) * 1982-07-22 1986-05-06 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
GB2132887A (en) * 1982-11-15 1984-07-18 Procter & Gamble Enteric-coated anti-inflammatory compositions
JPS59122425A (ja) * 1982-12-27 1984-07-14 Kaken Pharmaceut Co Ltd 持続性製剤およびその製造法
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4684516A (en) * 1983-08-01 1987-08-04 Alra Laboratories, Inc. Sustained release tablets and method of making same
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4522826A (en) * 1984-02-08 1985-06-11 Richardson-Vicks Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4585783A (en) * 1984-02-08 1986-04-29 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances

Also Published As

Publication number Publication date
KR880000090A (ko) 1988-03-23
ATE66370T1 (de) 1991-09-15
EP0250648B1 (de) 1991-08-21
KR930008956B1 (ko) 1993-09-17
DK616186A (da) 1987-12-26
FI88580C (fi) 1993-06-10
EP0250648A2 (de) 1988-01-07
NO173081B (no) 1993-07-19
GR3002579T3 (en) 1993-01-25
DE3681031D1 (de) 1991-09-26
NZ218734A (en) 1990-03-27
AU6680786A (en) 1988-01-07
DK616186D0 (da) 1986-12-19
CN1023191C (zh) 1993-12-22
NO865195L (no) 1987-12-28
NO173081C (no) 1993-10-27
FI88580B (fi) 1993-02-26
ZA869586B (en) 1988-07-27
CH669523A5 (fi) 1989-03-31
CN86108644A (zh) 1988-01-06
NO865195D0 (no) 1986-12-19
EP0250648A3 (en) 1988-03-23
US4867987A (en) 1989-09-19
ES2029228T3 (es) 1992-08-01
IL81045A0 (en) 1987-03-31
AU590370B2 (en) 1989-11-02
FI865227A0 (fi) 1986-12-19
IL81045A (en) 1990-11-05
JPS635020A (ja) 1988-01-11
CA1276560C (en) 1990-11-20

Similar Documents

Publication Publication Date Title
FI865227A0 (fi) Foerfarande foer framstaellning av ett depot-preparat.
DK394685A (da) Pelletpraeparat og fremstilling deraf
GR3004448T3 (fi)
AU4927090A (en) Medicaments having controlled release of the active compound
IL90435A (en) 4-(quinoline-2-yl-methoxy) phenylacetic acid derivatives, their preparation and pharmaceutical compositions containing them
GEP20002013B (en) Therapeutical Means
CA2124218A1 (en) Cytotoxic drug therapy
AU1578688A (en) Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines
NO813826L (no) Smertenedbrytende legemiddel-presslegemer
EP0171528A3 (en) Controlled release pharmaceutical preparations
DK1167354T3 (da) Racemisk huperzin A
CA2039053A1 (en) Material for adsorbing pyrogen
ZA884622B (en) Pharmaceutical compositions in the form of pellets with enzymatically controlled release of the pharmaceutical,substance
FR2385398B1 (fi)
DE69130063D1 (de) Antivirales arzneimittel enthaltend prostratin
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
DE59001005D1 (de) Hilfsmittelfreie riboflavingranulate.
AU7095687A (en) Pellet-containing pharmaceutical compositions
ES2082523T3 (es) Un medicamento de accion retardada que contiene ibuprofen y su empleo.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: MEPHA AG